Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| dendritic cell | 7 studies | 26% ± 11% | |
| endothelial cell | 3 studies | 17% ± 1% | |
| epithelial cell | 3 studies | 23% ± 2% | |
| GABAergic neuron | 3 studies | 37% ± 7% | |
| glutamatergic neuron | 3 studies | 43% ± 8% | |
| oligodendrocyte precursor cell | 3 studies | 22% ± 4% | |
| astrocyte | 3 studies | 16% ± 1% | |
| oligodendrocyte | 3 studies | 16% ± 0% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 30% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 1282.24 | 21 / 21 | 100% | 11.23 | 504 / 504 |
| breast | 100% | 1200.33 | 459 / 459 | 100% | 10.92 | 1118 / 1118 |
| esophagus | 100% | 938.38 | 1445 / 1445 | 100% | 10.88 | 183 / 183 |
| lung | 100% | 1158.84 | 578 / 578 | 100% | 11.42 | 1155 / 1155 |
| ovary | 100% | 1034.19 | 180 / 180 | 100% | 11.66 | 430 / 430 |
| uterus | 100% | 1512.84 | 170 / 170 | 100% | 12.46 | 458 / 459 |
| intestine | 100% | 1164.51 | 966 / 966 | 99% | 9.54 | 524 / 527 |
| prostate | 100% | 1111.84 | 245 / 245 | 99% | 7.80 | 499 / 502 |
| thymus | 100% | 1073.06 | 653 / 653 | 99% | 8.05 | 601 / 605 |
| stomach | 100% | 786.18 | 359 / 359 | 99% | 9.48 | 284 / 286 |
| pancreas | 100% | 838.46 | 328 / 328 | 99% | 8.99 | 176 / 178 |
| brain | 99% | 689.90 | 2610 / 2642 | 100% | 11.15 | 705 / 705 |
| adrenal gland | 100% | 1291.72 | 258 / 258 | 98% | 8.22 | 226 / 230 |
| kidney | 100% | 802.40 | 89 / 89 | 98% | 9.05 | 880 / 901 |
| skin | 100% | 1510.10 | 1809 / 1809 | 97% | 11.39 | 458 / 472 |
| liver | 100% | 661.93 | 226 / 226 | 89% | 4.48 | 362 / 406 |
| adipose | 100% | 1261.14 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1065.09 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 11.25 | 29 / 29 |
| spleen | 100% | 1710.49 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 15.27 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.71 | 1 / 1 |
| heart | 98% | 683.28 | 847 / 861 | 0% | 0 | 0 / 0 |
| muscle | 89% | 372.47 | 711 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 83% | 698.89 | 772 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 79% | 4.00 | 63 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0060537 | Biological process | muscle tissue development |
| GO_0045747 | Biological process | positive regulation of Notch signaling pathway |
| GO_0010470 | Biological process | regulation of gastrulation |
| GO_0048318 | Biological process | axial mesoderm development |
| GO_0018242 | Biological process | protein O-linked glycosylation via serine |
| GO_0072359 | Biological process | circulatory system development |
| GO_0007369 | Biological process | gastrulation |
| GO_0006493 | Biological process | protein O-linked glycosylation |
| GO_0001756 | Biological process | somitogenesis |
| GO_0048339 | Biological process | paraxial mesoderm development |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0012505 | Cellular component | endomembrane system |
| GO_0046527 | Molecular function | glucosyltransferase activity |
| GO_0140562 | Molecular function | EGF-domain serine xylosyltransferase activity |
| GO_0035251 | Molecular function | UDP-glucosyltransferase activity |
| GO_0035252 | Molecular function | UDP-xylosyltransferase activity |
| GO_0140561 | Molecular function | EGF-domain serine glucosyltransferase activity |
| Gene name | POGLUT1 |
| Protein name | Protein O-glucosyltransferase 1 (cDNA FLJ53000, highly similar to CAP10-like 46 kDa protein) Protein O-glucosyltransferase 1 (EC 2.4.1.376) (CAP10-like 46 kDa protein) (hCLP46) (KTEL motif-containing protein 1) (Myelodysplastic syndromes relative protein) (O-glucosyltransferase Rumi homolog) (hRumi) (Protein O-xylosyltransferase POGLUT1) (EC 2.4.2.63) Protein O-glucosyltransferase 1 |
| Synonyms | C3orf9 MDSRP UNQ490/PRO1006 CLP46 KTELC1 MDS010 |
| Description | FUNCTION: Dual specificity glycosyltransferase that catalyzes the transfer of glucose and xylose from UDP-glucose and UDP-xylose, respectively, to a serine residue found in the consensus sequence of C-X-S-X-P-C . Specifically targets extracellular EGF repeats of protein such as CRB2, F7, F9 and NOTCH2 . Acts as a positive regulator of Notch signaling by mediating O-glucosylation of Notch, leading to regulate muscle development . Notch glucosylation does not affect Notch ligand binding . Required during early development to promote gastrulation: acts by mediating O-glucosylation of CRB2, which is required for CRB2 localization to the cell membrane (By similarity). . |
| Accessions | B4DVA9 F8WEW4 ENST00000476573.5 ENST00000647766.1 Q8NBL1 H7C5H0 ENST00000486607.5 ENST00000497447.5 ENST00000295588.9 ENST00000460339.1 F8WDC4 |